Trial Profile
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of alefacept when given in combination with methotrexate in subjects with psoriatic arthritis with an open-label retreatment course
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Alefacept (Primary) ; Methotrexate
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 06 May 2008 New trial record.